HF
OTLK icon

HRT Financial’s Outlook Therapeutics OTLK Stock Holding History

HRT Financial’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
784,904
+717,145
+1,058% +$445K ﹤0.01% 2030
2026
Q1 		$13K Buy
+67,759
New +$29.3K ﹤0.01% 3613
2025
Q3 		– Sell
-35,399
Closed -$56K – 3447
2025
Q2 		$56K Buy
+35,399
New +$56.4K ﹤0.01% 2295
2024
Q2 		– Sell
-28,623
Closed -$341K – 2863
2024
Q1 		$341K Buy
+28,623
New +$231K ﹤0.01% 1482
2022
Q3 		– Sell
-1,006
Closed -$20K – 3309
2022
Q2 		$20K Buy
+1,006
New +$28.9K ﹤0.01% 2606
2021
Q2 		– Sell
-1,434
Closed -$64K – 3339
2021
Q1 		$64K Buy
+1,434
New +$54.9K ﹤0.01% 2516

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's OTLK Position: Q2 2026 in Review

HRT Financial increased its Outlook Therapeutics (OTLK) stake by 1,058% in Q2 2026, buying an estimated $445K and bringing the position to 784,904 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

HRT Financial first reported a position in OTLK in Q1 2021 and has held it in 6 quarters since. 68 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • HRT Financial held 784,904 shares of Outlook Therapeutics worth $1.25M as of Q2 2026.
  • HRT Financial bought 717,145 Outlook Therapeutics shares in Q2 2026, an estimated $445K.
  • Outlook Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2030 holding.
  • HRT Financial first reported a position in Outlook Therapeutics in Q1 2021 and has held it in 6 quarters since.
  • 68 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.